Increasing endostatin might predict the progression of CKD and this was also shown in two independent longitudinal community-based cohorts of elderly subjects [5] and in patients with type 2 diabetes [9], where higher circulating endostatin concentrations were associated with increased risk of developing CKD. Here, COL18A1 is linked to chronic kidney disease.